Akèy › Metiyè › Chemists › Seattle, WA
Chemists nan Seattle, WA: Salè H-1B
26 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Seattle, WA. Salè baz medyàn ofri $83,200; mwatye mitan $69,828–$95,000.
Demann (LCA)26
Salè medyan ofri$83,200
Mwatye salè yo$69,828–$95,000
10yèm–90yèm pousantaj$66,000–$133,600
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $76,234 |
| Nivo II (kalifye) | $77,953 |
| Nivo III (eksperyans) | $93,300 |
| Nivo IV (plen kompetans) | $144,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| University of Washington | 8 | $69,552 |
| Omeros Corporation | 5 | $93,300 |
| Bristol-Myers Squibb Company | 3 | $144,000 |
| Cardinal Health | 2 | $94,328 |
| AltPep Corporation | 1 | $72,946 |
| Gilead Sciences, Inc. | 1 | $82,960 |
| CQV Associates Inc. | 1 | $83,200 |
| Shirley Diagnostics, Inc. | 1 | $72,426 |
| Battelle Memorial Institute | 1 | $90,235 |
| The University of Iowa | 1 | $62,232 |
| FOM Technologies Inc | 1 | — |
| Aionics Holdings, Inc. | 1 | $115,000 |
Tit travay
- Postdoctoral Scholar4
- Sr. Principal Research Associate, Formulations3
- Principal Scientist, Residual, Ancillary Materials and PC2
- Research Scientist/Engineer 32
- Sr. Engineer, Product2
- Chemist1
- Senior Research Associate, Analytical Development1
- Acting Instructor1
- Research Scientist/Engineer 21
- Sr Research Associate I, Medicinal Chemistry1
- Quality Engineer1
- Analytical Chemist1
- Principal Scientist1
- Materials Scientist (Chemist)1
- Postdoctoral Research Scholar1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).